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Previewsduplication events producing additional
adaptors sharing with the receptor a TIR
domain enabled the compartmentaliza-
tion of MyD88 (and also TRIF) and intro-
duced flexibility in the signaling (Barton
and Kagan, 2009). If the introduction of
compartmentalization as an adjustment
variable in organisms containing ten or
so TLRs (not to mention the members
of the IL-1R family, which also signal
through MyD88) and four adaptors
explains the need for sorting adaptors in
mammals, what may be the driving force
for anchoring dMyD88 to the plasma
membrane in insects? One intriguing
hypothesis is that the explanation lies
in the involvement of the Toll pathway in
functions other than innate immunity in
insects, namely the differentiation of the
dorsoventral axis in embryos (Nunes da
Fonseca et al., 2008). Indeed, Marek and
Kagan (2012) observe that a truncated
version of dMyD88 deleted of its CTE is
not completely inactive and can rescue
to some extent the immunity phenotype
of dMyD88 mutant flies. However, it
does not rescue at all the embryonic
phenotype (Marek and Kagan, 2012).
This indicates that whereas the CTE
increases the efficiency and reliability of
Toll signaling functions in immunity in
adult flies, it plays above all a crucial role
during development. Thus, the advent ofthis domain in insects may relate to the
appearance of a new function for Toll
receptors, in the establishment of the
embryonic dorsoventral axis. Interest-
ingly, another adaptor, the zinc finger
protein Weckle, participates in the
assembly of the dMyD88-Tube-Pelle
signaling complex in embryos. The fact
that this adaptor appears to be largely
dispensable in adult flies further points
to specific requirements for Toll signaling
in the early Drosophila embryo (Chen
et al., 2006). The sorting of dMyD88 at
the plasma membrane, in proximity to
the receptor, may allow Toll to efficiently
respond to developmental cues sensed
on the ventral side of the embryo in the
particular context of the syncytial
embryos, which contain high concentra-
tions of lipid vesicles and vitellogenin.
In summary, the report of Marek and
Kagan (2012) highlights the importance
of PI recognition for signal transduction.
The CTE from dMyD88 represents a
tool to understand how proteins read
the so-called PI code, and it will be inter-
esting to characterize its structure (Kuta-
teladze, 2010). The fact that TIRAP in
mammals and dMyD88 in flies indepen-
dently acquired the capacity to target
PI(4,5)P2 suggests that there may be
more to this phosphoinositide than just
providing a landing site for these adap-Immunitytors. Time and further experiments will
tell whether PI(4,5)P2 also plays a more
active role in the function of dMyD88, for
example in the promotion of endocytosis,
which participates in Toll signaling in
Drosophila (Huang et al., 2010; Lund
et al., 2010).
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Cell death needs to be detected by immune cells. In this issue of Immunity, Ahrens et al. (2012) and Zhang
et al. (2012) show that actin filaments become exposed on necrotic cells and act as ligands for the C-type
lectin receptor Clec9a.Cell damage or death is a sign that some-
thing is amiss and quick responses by the
immune system are required to initiate
tissue repair and contain the damage.
In contrast to infection when foreign
invaders trespass, sterile injury concerns
damaged cells and therefore a warningmechanism is required to recognize
damage to self. In this issue of Immunity,
two studies show that actin filaments,
one of the most abundant protein struc-
tures in eukaryotic cells, serve as a
danger signal when becoming exposed
to immune cells due to cell damage(Figure 1) (Ahrens et al., 2012; Zhang
et al., 2012).
Pattern recognition receptors (PRRs)
sense invading pathogens through highly
conserved structures called pathogen-
associated molecular patterns (PAMPs)
and include Toll-like receptors (TLRs)36, April 20, 2012 ª2012 Elsevier Inc. 557
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Figure 1. Clec9a Recognizes Actin
Filaments Exposed in Necrotic Cells
The membrane skeleton lies just beneath the
plasma membrane and is a multiprotein complex
of F-actin, spectrin, and band 4.1. Spectrin cross-
links short F-actin filaments forming a network of
scaffolding proteins that structurally support the
plasmamembrane. Protein 4.1 mediates formation
of a ternary complex with spectrin and actin (top
left). Necrosis leads to loss of membrane integrity,
exposing the actin cytoskeleton. The necrotic cell
is taken up by Clec9a+ DC subsets independently
of Clec9a. F-actin exposed on necrotic cells is
recognized by Clec9a, leading to Syk activation
and subsequent routing of necrotic cell into the
cross-presentation pathway. It is currently unclear
whether Syk activation by F-actin leads to addi-
tional effects such as gene transcription of inflam-
matory genes.
Immunity
Previewsand C-type lectin receptors (CLRs) (Akira
et al., 2006). Dendritic cells (DCs) express
a diverse array of PRRs that sense
invading pathogens and trigger signaling
pathways that lead to specific cytokine
responses and T cell priming (Geijtenbeek
and Gringhuis, 2009). Although less is
known about the mechanisms that
sense injury or cell death, similarities exist
between both sensing systems. Analo-
gous with PAMPs, damaged cells release
or act as damage-associated molecular
patterns (DAMPs) (Seong and Matzinger,
2004), which are sensed by innate recep-
tors leading to inflammatory responses.
DAMPs can be intracellular molecules
that are released upon cell damage and
loss of cell integrity such as ATP and
high-mobility group box 1 (HMGB1)
(Rock et al., 2011). Similar as PAMPs,
some DAMPs induce DC maturation and
T helper cell differentiation. Some of the
DAMP receptors are PRRs, such as558 Immunity 36, April 20, 2012 ª2012 ElsevTLR4 that recognizes DAMPs such as
HMBG1 (Rock et al., 2011). Recently,
the CLR Clec9a (DNGR-1) was identified
as a receptor for necrotic cells that is re-
quired for cross-presentation of necrotic
cell-associated antigens (Sancho et al.,
2009). Notably, Clec9a expression is
restricted to DC subsets specialized in
cross-presentation i.e., the murine
CD8a+ DC and the human equivalent
BDCA3+ DC subsets (Sancho et al.,
2008; Huysamen et al., 2008). Cross-
presentation of exogenous antigens by
DCs is important for activation of CD8+
T cell against tumors. Sancho et al.
(2009) showed that Clec9a recognizes
necrotic cells and activation leads to
cross-presentation of antigens associ-
ated with the necrotic cells to CD8+
T cells (Sancho et al., 2009). Thus, Clec9a
might be a good target in vaccination
strategies.
However, functional studies on Clec9a
have been hampered by the failure to
identify the ligand. Clec9a recognizes
both necrotic cells and permeabilized
cells (Sancho et al., 2009), suggesting
that the ligand is present within the cell
and becomes exposed after loss of
membrane integrity. In this issue of
Immunity, two papers have identified
actin filaments as ligands for Clec9a,
which will help unraveling the function of
Clec9a (Zhang et al., 2012; Ahrens et al.,
2012). In hindsight, identification of the
ligand for Clec9a has been hampered by
the nature of the ligand itself, given that
actin filaments consist as large multipro-
tein complexes that are difficult to purify
and the presence of many different
proteins complicates identification of the
exact ligand. Actin is one of the most
abundant, highly conserved and versatile
proteins found in eukaryotic cells. It is
a 42 kDa globular protein that undergoes
cycles of polymerization and disassembly
between its globular (G-actin) and fila-
mentous (F-actin) form. The formation of
F-actin is highly regulated; nucleator
proteins interact with actin to catalyze
polarization, whereas actin binding pro-
teins organize and stabilize filaments
into specific structures (Michelot and
Drubin, 2011). Initial experiments by the
two studies in Immunity suggested that
Clec9a recognized high molecular weight
(MW) complexes of actin with different
actin-binding proteins, and attempts to
pinpoint F-actin as the specific ligandier Inc.met with difficulties (Zhang et al., 2012;
Ahrens et al., 2012).
Both studies set out to identify the
Clec9a ligand by pull-down assays with
recombinant Clec9a and subsequent
mass spectrometric analyses. Not only
actin but also actin-binding proteins
such as spectrin and a-actinin were iden-
tified in the isolated fractions recognized
by Clec9a (Ahrens et al., 2012; Zhang
et al., 2012). Initially, Zhang et al. focused
on a complex of spectrin and actin as
a potential ligand. Spectrin comprises
the cell-membrane skeleton together
with F-actin and other proteins (Figure 1).
HighMWcomplexes of spectrin with actin
in contrast to monomeric spectrin were
recognized by Clec9a (Zhang et al.,
2012). Reassociation of monomeric spec-
trin with actin resulted in high MW
complexes and restored recognition by
Clec9a (Zhang et al., 2012). Similarly,
Clec9a recognized its ligand when cell
lysates were incubated under actin-poly-
merization conditions whereas depoly-
merizaton conditions decreased binding
(Ahrens et al., 2012). Clec9a also recog-
nized complexes of actin with another
actin-binding protein, a-actinin (Zhang
et al., 2012). These data suggest that
Clec9a specifically recognizes actin fila-
ments within the complexes. Indeed, co-
sedimentation assays showed that
Clec9a bound directly to F-actin but not
G-actin and addition of a-actinin
increased cosedimentation (Ahrens
et al., 2012). Thus, F-actin but not mono-
meric G-actin is a ligand for Clec9a
(Zhang et al., 2012; Ahrens et al., 2012)
and actin-binding proteins probably
increase Clec9a recognition by stabilizing
or organizing actin filaments into bundles
or networks.
The cell-membrane skeleton deter-
mines membrane architecture and sup-
ports the plasma membrane (Figure 1)
and Clec9a colocalized with actin fila-
ments present in the cytoskeleton in
multiple cell types and tissues across
species (Zhang et al., 2012; Ahrens
et al., 2012). The close proximity with
the cell membrane suggests that
damage to the membrane exposes the
skeleton and in particular F-actin fila-
ments to the immune system as a sign
of cell damage (Figure 1). Furthermore,
Clec9a also recognized late-apoptotic
cells probably because of the loss of
membrane integrity and actin exposure
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Previews(Zhang et al., 2012). Further studies on
the regulation of actin (de)polymerization
as well as its exposure to the outside
during necrosis or apoptosis will be
required to understand the role of actin-
Clec9a interaction in recognition of cell
death.
The exposed actin filaments need to
be recognized by Clec9a on DCs. Both
studies have not shown that endogenous
Clec9a on DCs is able to recognize the
actin filaments in necrotic cells (Zhang
et al., 2012; Ahrens et al., 2012). Clec9a
is essential to routing of necrotic cell
cargo into the cross-presentation
pathway but not for the interaction of
DCs with necrotic cells (Sancho et al.,
2009). These data suggest that necrotic
cells with exposed actin filaments need
to be brought into close contact with
Clec9a for triggering and subsequent
routing into the cross-presentation
pathway (Figure 1). It is unclear how
necrotic cells are taken up by DCs and
whether Clec9a on CD8a+ DCs indeed
interacts with actin-filaments exposed
on dead or damaged cells.
CLRs such as dectin-1 have been
shown to induce adaptive immunity
through activation of the tyrosine kinase
Syk (Geijtenbeek and Gringhuis, 2009).
Cross-presentation by Clec9a is coupled
to Syk activation as Syk becomes
phosphorylated upon DC contact with
necrotic cells and gene deletion of Syk
blocks Clec9a-dependent cross-presen-
tation (Sancho et al., 2009). It will be
important to identify the Syk-dependent
signaling pathway responsible for routing
of antigens. Using a Clec9a+ reporter-
cell line, Ahrens et al. (2012) showed
that F-actin also activated Syk. Necrotic
cells induced Syk-dependent reporteractivity in the Clec9a+ cell line but
pretreatment of cells with destabilizing
or stabilizing actin agents before freeze-
thaw cycles either decreased or in-
creased Syk reporter activity, respectively
(Ahrens et al., 2012). These data strongly
support a role for actin in recognition of
necrotic cells.
Clec9a triggering by necrotic cells or
crosslinking does not lead to DC matura-
tion and cytokine responses (Schreibelt
et al., 2012; Ahrens et al., 2012). These
data suggest that Clec9a is not involved
in immune regulation as opposed to other
CLRs (Geijtenbeek and Gringhuis, 2009).
Necrosis is a clear sign of danger and
therefore it is striking that the recognition
by Clec9a does not induce any immune
activation or modulation. Perhaps the
identification of F-actin will shed more
light on this unexpected finding. Similarly,
it is unclear why Syk activation by
Clec9a does not lead to any immune
induction as has been shown for other
Syk-coupled CLRs. Specific coligations
of other PRRs or DAMP receptors might
be required to induce inflammatory
responses.
F-actin is very abundant and is ideally
suited as a danger signal for damaged
cells, and thus F-actin might be a ligand
for other DAMP receptors especially
given that cross-presentation might not
be the most obvious immunological
response to necrosis because most
necrosis will be caused by damage or
sterile injury in absence of pathogens.
Notably, yeast actin also interacted with
Clec9a when stabilized (Ahrens et al.,
2012), indicating that Clec9a might func-
tion as a PRR for detecting partially
degraded pathogens in vesicles and for
subsequent routing of pathogenic anti-Immunitygens into the cross-presentation route.
With the identification of F-actin as
a ligand for Clec9a it will be possible to
further delineate the intracellular routing
of antigens recognized by Clec9a as well
as investigate the role of F-actin as a
DAMP in inducing immune responses to
necrosis.REFERENCES
Ahrens, S., Zelenay, A., Sancho, D., Hanc, P.,
Kjaer, S., Feest, C., Fletcher, G., Durkin, C., Post-
ogo, A., Stehel, M., et al. (2012). Immunity 36, this
issue, 635–645.
Akira, S., Uematsu, S., and Takeuchi, O. (2006).
Cell 124, 783–801.
Geijtenbeek, T.B., and Gringhuis, S.I. (2009). Nat.
Rev. Immunol. 9, 465–479.
Huysamen, C., Willment, J.A., Dennehy, K.M., and
Brown, G.D. (2008). J. Biol. Chem. 283, 16693–
16701.
Michelot, A., and Drubin, D.G. (2011). Curr. Biol.
21, R560–R569.
Rock, K.L., Lai, J.J., and Kono, H. (2011). Immunol.
Rev. 243, 191–205.
Sancho, D., Moura˜o-Sa´, D., Joffre, O.P., Schulz,
O., Rogers, N.C., Pennington, D.J., Carlyle, J.R.,
and Reis e Sousa, C. (2008). J. Clin. Invest. 118,
2098–2110.
Sancho, D., Joffre, O.P., Keller, A.M., Rogers,
N.C., Martı´nez, D., Hernanz-Falco´n, P., Rosewell,
I., and Reis e Sousa, C. (2009). Nature 458,
899–903.
Schreibelt, G., Klinkenberg, L.J., Cruz, L.J.,
Tacken, P.J., Tel, J., Kreutz, M., Adema, G.J.,
Brown, G.D., Figdor, C.G., and de Vries, I.J.
(2012). Blood 119, 2284–2292.
Seong, S.Y., and Matzinger, P. (2004). Nat. Rev.
Immunol. 4, 469–478.
Zhang, J.-G., Czabotar, P.E., Policheni, A.N., Ca-
minschi, I., San Wan, S., Kitsoulis, S., Tullett,
K.M., Robin, A.Y., Brammananth, R., van Delft,
M.F., et al. (2012). Immunity 36, this issue,
646–657.36, April 20, 2012 ª2012 Elsevier Inc. 559
